|
Market Closed -
Nasdaq
16:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 109.66 USD | +1.80% |
|
+0.31% | +62.94% |
| Market Cap | 12.23B 10.55B 9.94B 9.05B 16.92B 1,155B 17.05B 118B 45.65B 590B 45.91B 44.91B 1,940B | P/E 2026 * |
14.9x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 13.57B 11.71B 11.03B 10.05B 18.78B 1,282B 18.92B 131B 50.67B 655B 50.96B 49.84B 2,153B | EV / Sales 2026 * |
7.32x | EV / Sales 2027 * | 6.12x |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Halozyme Therapeutics, Inc.
| 1 day | +1.80% | ||
| 1 week | +0.31% | ||
| Current month | +2.98% | ||
| 1 month | +32.86% | ||
| 3 months | +60.93% | ||
| 6 months | +57.72% | ||
| Current year | +62.94% |
| 1 week | 103.47 |  | 109.76 |
| 1 month | 81.75 | | 109.76 |
| Current year | 61.32 | | 109.76 |
| 1 year | 61.22 | | 109.76 |
| 3 years | 32.83 | | 109.76 |
| 5 years | 29.85 | | 109.76 |
| 10 years | 8.18 | | 109.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/19/26 | Exercice | Chief Executive Officer | 60,000 | 0.0506% | ||
| 8/10/26 | Sell | Director | -1,626 | 0.0014% | ||
| 7/8/26 | Exercice | Chief Executive Officer | 5,769 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | +0.31% | +49.91% | +156.10% | 12.23B | |
| +1.19% | -3.07% | +80.27% | +38.06% | 370B | |
| +0.18% | +0.47% | +28.79% | -16.07% | 70.44B | |
| -11.05% | -6.86% | -8.25% | -10.29% | 8.79B | |
| -3.03% | +2.25% | -11.94% | +5.12% | 5.08B | |
| -1.69% | -2.40% | -27.80% | +21.09% | 4.5B | |
| -3.55% | -2.68% | -34.57% | -3.62% | 3.11B | |
| +0.66% | -2.93% | -2.42% | +35.52% | 2.54B | |
| -2.03% | -4.67% | -29.44% | -17.61% | 2.05B | |
| +2.53% | -1.73% | +257.94% | +1,255.80% | 1.73B | |
| Average | -1.50% | -2.59% | +30.25% | +146.41% | 48.02B | |
| Weighted average by Cap. | +0.70% | -1.55% | +67.33% | +35.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 1.6B 1.51B 1.37B 2.57B 175B 2.58B 17.84B 6.92B 89.53B 6.96B 6.81B 294B | 2.05B 1.77B 1.67B 1.52B 2.84B 194B 2.86B 19.73B 7.66B 99.04B 7.7B 7.53B 325B |
| Net income | 869M 749M 706M 643M 1.2B 82.07B 1.21B 8.36B 3.24B 41.96B 3.26B 3.19B 138B | 1.07B 921M 868M 791M 1.48B 101B 1.49B 10.27B 3.99B 51.57B 4.01B 3.92B 169B |
| Net Debt | 1.34B 1.16B 1.09B 995M 1.86B 127B 1.87B 12.93B 5.02B 64.91B 5.05B 4.94B 213B | 320M 276M 260M 237M 442M 30.18B 446M 3.07B 1.19B 15.43B 1.2B 1.17B 50.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | US$109.66 | +1.80% | 1,619,112 |
| 26-09-01 | US$107.72 | +1.16% | 1,058,736 |
| 26-08-31 | US$106.49 | +1.08% | 1,280,007 |
| 26-08-28 | US$105.35 | -1.47% | 1,681,929 |
| 26-08-27 | US$106.92 | -0.13% | 1,364,730 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
